Celgene France

Last updated: 13.02.2014

Address: 16/18, Rue du Quatre Septembre
75002 Paris

Tel: +33 1 53 42 43 00

Web: http://www.celgene.fr/

Company description

Celgene is a multinational biopharmaceutical company committed to improving the lives of patients worldwide.

Celgene seeks to deliver truly innovative and life-changing drugs for our patients. It’s mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

Thanks to the establishment of its structure in France, a 100% subsidiary of Celgene Corporation, Celgene France ensures its presence on the French health market. Celgene France, besides the marketing of drugs, will establish many clinical trials of new molecules derived from the R&D of Celgene. These, of course, will be conducted in cooperation with the most recognized French medical institutions.

Products and services

There are numerous clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin’s lymphoma (NHL), glioblastoma, and ovarian, pancreatic and prostate cancer.

Global Products

ISTODAX® (romidepsin) for injection

REVLIMID® (lenalidomide)

THALOMID® (thalidomide)

VIDAZA® (azacitidine for injection)

LifebankUSA (placental and cord blood banking)



We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here